Oxon Epidemiology

OXON Epidemiology is a European full-service Contract Research Organization (CRO) specialising in the generation of Real-World Evidence (RWE) via primary data collection, secondary data and hybrid observational studies, pragmatic trials, synthesis research, and data analysis and modelling of drugs and devices in all major therapeutic areas. Our collaborative approach—partnering with academic institutions and clients—combined with our extensive expertise in observational studies, patient registries, and complex study designs, ensures the highest level of scientific rigor and impactful results. This makes us a trusted partner for generating meaningful RWE that meets regulatory standards and informs critical healthcare decision-making. By merging quality science with operational excellence, we provide comprehensive RWE solutions for safety assessments, Health Economics and Outcomes Research (HEOR), market access strategies, drug development, and marketing initiatives, playing our role in improving patient care and public health. • Multi-country field, chart review and database epidemiological studies • Patient registries • Pragmatic Trials • Systematic Reviews & Meta-analysis • PASS and PAES studies • Risk minimisation studies • Risk management • Statistical signal detection & analysis • Quantitative benefit-risk analysis for CTD / PBRER • Patient reported outcomes • Health economics & modelling • Meta-analysis and Evidence strategy